Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclase

Abstract

Abacavir competitively inhibits guanylyl cyclase, leading to platelet hyperreactivity. This may explain the observed increased risk of myocardial infarction in HIV patients taking abacavir.